HK1169168A1 - Use of dppiv/seprase as a marker for cancer dppiv/seprase - Google Patents

Use of dppiv/seprase as a marker for cancer dppiv/seprase

Info

Publication number
HK1169168A1
HK1169168A1 HK12109860.4A HK12109860A HK1169168A1 HK 1169168 A1 HK1169168 A1 HK 1169168A1 HK 12109860 A HK12109860 A HK 12109860A HK 1169168 A1 HK1169168 A1 HK 1169168A1
Authority
HK
Hong Kong
Prior art keywords
seprase
dppiv
marker
cancer
cancer dppiv
Prior art date
Application number
HK12109860.4A
Other languages
English (en)
Chinese (zh)
Inventor
Lange Magdalena Swiatek-De
Johann Karl
Wolfgang Rollinger
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1169168A1 publication Critical patent/HK1169168A1/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK12109860.4A 2009-05-04 2012-10-08 Use of dppiv/seprase as a marker for cancer dppiv/seprase HK1169168A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09006097 2009-05-04
PCT/EP2010/002544 WO2010127782A1 (en) 2009-05-04 2010-04-26 Use of dppiv/seprase as a marker for cancer

Publications (1)

Publication Number Publication Date
HK1169168A1 true HK1169168A1 (en) 2013-01-18

Family

ID=40796163

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12109860.4A HK1169168A1 (en) 2009-05-04 2012-10-08 Use of dppiv/seprase as a marker for cancer dppiv/seprase

Country Status (7)

Country Link
EP (1) EP2427772B1 (xx)
JP (1) JP5312684B2 (xx)
CN (1) CN102414565B (xx)
CA (1) CA2760735C (xx)
ES (1) ES2533428T3 (xx)
HK (1) HK1169168A1 (xx)
WO (1) WO2010127782A1 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014509736A (ja) * 2011-03-11 2014-04-21 エフ．ホフマン−ラ ロシュ アーゲー 慢性閉塞性肺疾患（ｃｏｐｄ）のマーカーとしてのセプラーゼ
JP5976692B2 (ja) * 2011-03-11 2016-08-24 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 慢性閉塞性肺疾患（ｃｏｐｄ）のマーカーとしてのｆｅｎ１
CN104081202A (zh) 2011-09-12 2014-10-01 克里蒂科斯有限责任公司 检测靶分子的非侵入性方法
CN103163303B (zh) * 2012-06-19 2016-02-24 中国医学科学院肿瘤医院 辅助诊断肺腺癌患者的试剂盒
CN103175969B (zh) * 2012-06-19 2015-09-02 中国医学科学院肿瘤医院 辅助诊断肺鳞癌患者的试剂盒
EP2972375A2 (en) * 2013-03-13 2016-01-20 Creatics LLC Methods and compositions for detecting pancreatic cancer
WO2014190450A1 (zh) * 2013-05-28 2014-12-04 中国医学科学院肿瘤医院 辅助诊断肺鳞癌患者的试剂盒
EP2916134B1 (en) 2014-03-05 2017-08-16 Roche Diagnostics GmbH Use of Seprase for differential diagnosis of acute dyspnea
US10383956B2 (en) 2014-07-11 2019-08-20 The University Of Tokyo Fluorescent probe for detecting dipeptidyl peptidase IV
ES2813829T3 (es) * 2014-08-22 2021-03-25 Abbott Lab Métodos para la detección temprana del cáncer colorrectal
KR20220054710A (ko) 2014-11-13 2022-05-03 더 존스 홉킨스 유니버시티 관문 차단 및 미소부수체 불안정성
CN107326065B (zh) * 2016-04-29 2022-07-29 博尔诚（北京）科技有限公司 一种基因标识物的筛选方法及其应用
JP2018035137A (ja) 2016-07-13 2018-03-08 マブイミューン ダイアグノスティックス エイジーＭａｂｉｍｍｕｎｅ Ｄｉａｇｎｏｓｔｉｃｓ Ａｇ 新規な抗線維芽細胞活性化タンパク質（ｆａｐ）結合薬剤およびその使用
CN112540176B (zh) * 2020-07-08 2021-09-28 深圳霁因生物医药转化研究院 用于诊断fap表达异常相关疾病的试剂盒、方法及计算机可读存储介质

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6573096B1 (en) * 2000-04-01 2003-06-03 The Research Foundation At State University Of New York Compositions and methods for inhibition of cancer invasion and angiogenesis
EP1184666A3 (en) * 2000-08-21 2002-04-10 Roche Diagnostics GmbH Auxiliary haptens and haptenylated agents in displacement immunoassays
AU2001288437C1 (en) * 2000-09-09 2009-05-21 The Research Foundation Of State University Of New York Method and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof
KR101376471B1 (ko) * 2006-03-13 2014-03-27 백톤 디킨슨 앤드 컴퍼니 디펩티딜 펩티다제-관련 질병 상태의 진단 및 예후
JP2008118915A (ja) * 2006-11-10 2008-05-29 Kazuto Nishio 胃癌高発現遺伝子特定による胃癌診断および創薬への利用

Also Published As

Publication number Publication date
CN102414565B (zh) 2014-09-24
CN102414565A (zh) 2012-04-11
JP2012526267A (ja) 2012-10-25
JP5312684B2 (ja) 2013-10-09
CA2760735A1 (en) 2010-11-11
WO2010127782A1 (en) 2010-11-11
CA2760735C (en) 2016-12-06
ES2533428T3 (es) 2015-04-10
EP2427772B1 (en) 2015-01-21
EP2427772A1 (en) 2012-03-14

Similar Documents

Publication Publication Date Title
HK1169168A1 (en) Use of dppiv/seprase as a marker for cancer dppiv/seprase
HK1166130A1 (en) Use of s-erbb-3 as a marker for cancer s-erbb-3
EP2445343A4 (en) PRODRUGS OF NH ACID COMPOUNDS
HK1162669A1 (en) Pacap as a marker for cancer pacap
ZA201108131B (en) Dihydroorotate- dehydrogenasee inhibitors as virostatic compounds
GB2474428B (en) Umbilical
AU328687S (en) USB adaptor
SI2432884T1 (sl) Plazmid brez antibiotika
GB2475952B (en) Fifth wheel secondary lock
EP2495561A4 (en) MARKER FOR DETERMINING SENSITIVITY TO ANTICREMENT
ZA201106972B (en) Pointing agent for stone
ZA201200888B (en) New tumor marker
HK1160218A1 (en) Asc as a marker for lung cancer asc
GB0908071D0 (en) Marker
HK1165204A1 (en) Cybp as a marker of lung cancer cybp
HK1169314A1 (zh) δ-生育酚-碳水化合物作為脫色劑的用途
GB2474751B (en) Transfer wheel markers
GB0905964D0 (en) Marker
IL220316A (en) Mitf as a marker of cancer tendency
EP2250290A4 (en) PTTG1 AS A BIOMARKER FOR CANCER TREATMENT
EP2473679A4 (en) TOUCH MARKER
GB0809689D0 (en) Markers for prostate cancee
GB0920010D0 (en) Markers of pre-eclampsia
PL118678U1 (pl) Długopis
GB0922553D0 (en) Prognostic marker